ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Meglumine Diatrizoate Injection Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-4S14699
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Meglumine Diatrizoate Injection Market Research Report 2023
BUY CHAPTERS

Global Meglumine Diatrizoate Injection Market Research Report 2025

Code: QYRE-Auto-4S14699
Report
May 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Advacare Pharma
Shanghai Xudong Haipu Pharmaceutical
Hunan Hansen Pharmaceutical
Lunan Pharmaceutical
Xi'an Hanfeng Pharmaceutical
Shanghai Bracco Sine Pharmaceutical

Meglumine Diatrizoate Injection Market

The global market for Meglumine Diatrizoate Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Meglumine injection, indicated as this contrast agent for intravenous and retrograde urography; Cerebral, thoracic, abdominal and limbs angiography, venography and CT; It can also be used for arthrography, fistula imaging, hysterosalpingography, endoscopic retrograde cholangiopancreatography (ERCP), sialography, and other tests. Meglumine injection should not be used in selective coronary angiography. It should not be used for myelography, ventriculography, or cisternography as it may induce neurotoxic symptoms.
The major consumer markets for Meglumine Diatrizoate Injection are North America, Europe and the Asia-Pacific region. With the gradual recovery of the global economy after the COVID-19 outbreak and the return of major economies to normal, the medical industry will see certain growth. As the global medical level continues to improve, more and more hospitals and clinics are able to perform MRI and CT imaging. Therefore, the demand for Meglumine Diatrizoate Injection will increase in the foreseeable time.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Meglumine Diatrizoate Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meglumine Diatrizoate Injection.
The Meglumine Diatrizoate Injection market size, estimations, and forecasts are provided in terms of sales volume (K Bottles) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Meglumine Diatrizoate Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Meglumine Diatrizoate Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Meglumine Diatrizoate Injection Market Report

Report Metric Details
Report Name Meglumine Diatrizoate Injection Market
Segment by Type
  • 1ml/0.3g
  • 20ml/15.2g
  • 20ml/12g
  • 100ml/60g
Segment by Application
  • Hospital
  • Clinic
  • Pharmacy
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AdvaCare Pharma, Shanghai Xudong Haipu Pharmaceutical, Hunan Hansen Pharmaceutical, Shanghai Bracco Sine Pharmaceutical, Lunan Pharmaceutical, Xi'an Hanfeng Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Meglumine Diatrizoate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Meglumine Diatrizoate Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Meglumine Diatrizoate Injection Market report?

Ans: The main players in the Meglumine Diatrizoate Injection Market are AdvaCare Pharma, Shanghai Xudong Haipu Pharmaceutical, Hunan Hansen Pharmaceutical, Shanghai Bracco Sine Pharmaceutical, Lunan Pharmaceutical, Xi'an Hanfeng Pharmaceutical

What are the Application segmentation covered in the Meglumine Diatrizoate Injection Market report?

Ans: The Applications covered in the Meglumine Diatrizoate Injection Market report are Hospital, Clinic, Pharmacy

What are the Type segmentation covered in the Meglumine Diatrizoate Injection Market report?

Ans: The Types covered in the Meglumine Diatrizoate Injection Market report are 1ml/0.3g, 20ml/15.2g, 20ml/12g, 100ml/60g

1 Meglumine Diatrizoate Injection Market Overview
1.1 Product Definition
1.2 Meglumine Diatrizoate Injection by Type
1.2.1 Global Meglumine Diatrizoate Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 1ml/0.3g
1.2.3 20ml/15.2g
1.2.4 20ml/12g
1.2.5 100ml/60g
1.3 Meglumine Diatrizoate Injection by Application
1.3.1 Global Meglumine Diatrizoate Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Global Meglumine Diatrizoate Injection Market Size Estimates and Forecasts
1.4.1 Global Meglumine Diatrizoate Injection Revenue 2020-2031
1.4.2 Global Meglumine Diatrizoate Injection Sales 2020-2031
1.4.3 Global Meglumine Diatrizoate Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Meglumine Diatrizoate Injection Market Competition by Manufacturers
2.1 Global Meglumine Diatrizoate Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Meglumine Diatrizoate Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Meglumine Diatrizoate Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Meglumine Diatrizoate Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Meglumine Diatrizoate Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Meglumine Diatrizoate Injection, Product Type & Application
2.7 Global Key Manufacturers of Meglumine Diatrizoate Injection, Date of Enter into This Industry
2.8 Global Meglumine Diatrizoate Injection Market Competitive Situation and Trends
2.8.1 Global Meglumine Diatrizoate Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Meglumine Diatrizoate Injection Players Market Share by Revenue
2.8.3 Global Meglumine Diatrizoate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Meglumine Diatrizoate Injection Market Scenario by Region
3.1 Global Meglumine Diatrizoate Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Meglumine Diatrizoate Injection Sales by Region: 2020-2031
3.2.1 Global Meglumine Diatrizoate Injection Sales by Region: 2020-2025
3.2.2 Global Meglumine Diatrizoate Injection Sales by Region: 2026-2031
3.3 Global Meglumine Diatrizoate Injection Revenue by Region: 2020-2031
3.3.1 Global Meglumine Diatrizoate Injection Revenue by Region: 2020-2025
3.3.2 Global Meglumine Diatrizoate Injection Revenue by Region: 2026-2031
3.4 North America Meglumine Diatrizoate Injection Market Facts & Figures by Country
3.4.1 North America Meglumine Diatrizoate Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Meglumine Diatrizoate Injection Sales by Country (2020-2031)
3.4.3 North America Meglumine Diatrizoate Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Meglumine Diatrizoate Injection Market Facts & Figures by Country
3.5.1 Europe Meglumine Diatrizoate Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Meglumine Diatrizoate Injection Sales by Country (2020-2031)
3.5.3 Europe Meglumine Diatrizoate Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Meglumine Diatrizoate Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Meglumine Diatrizoate Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Meglumine Diatrizoate Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Meglumine Diatrizoate Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Meglumine Diatrizoate Injection Market Facts & Figures by Country
3.7.1 Latin America Meglumine Diatrizoate Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Meglumine Diatrizoate Injection Sales by Country (2020-2031)
3.7.3 Latin America Meglumine Diatrizoate Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Meglumine Diatrizoate Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Meglumine Diatrizoate Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Meglumine Diatrizoate Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Meglumine Diatrizoate Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Meglumine Diatrizoate Injection Sales by Type (2020-2031)
4.1.1 Global Meglumine Diatrizoate Injection Sales by Type (2020-2025)
4.1.2 Global Meglumine Diatrizoate Injection Sales by Type (2026-2031)
4.1.3 Global Meglumine Diatrizoate Injection Sales Market Share by Type (2020-2031)
4.2 Global Meglumine Diatrizoate Injection Revenue by Type (2020-2031)
4.2.1 Global Meglumine Diatrizoate Injection Revenue by Type (2020-2025)
4.2.2 Global Meglumine Diatrizoate Injection Revenue by Type (2026-2031)
4.2.3 Global Meglumine Diatrizoate Injection Revenue Market Share by Type (2020-2031)
4.3 Global Meglumine Diatrizoate Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Meglumine Diatrizoate Injection Sales by Application (2020-2031)
5.1.1 Global Meglumine Diatrizoate Injection Sales by Application (2020-2025)
5.1.2 Global Meglumine Diatrizoate Injection Sales by Application (2026-2031)
5.1.3 Global Meglumine Diatrizoate Injection Sales Market Share by Application (2020-2031)
5.2 Global Meglumine Diatrizoate Injection Revenue by Application (2020-2031)
5.2.1 Global Meglumine Diatrizoate Injection Revenue by Application (2020-2025)
5.2.2 Global Meglumine Diatrizoate Injection Revenue by Application (2026-2031)
5.2.3 Global Meglumine Diatrizoate Injection Revenue Market Share by Application (2020-2031)
5.3 Global Meglumine Diatrizoate Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AdvaCare Pharma
6.1.1 AdvaCare Pharma Company Information
6.1.2 AdvaCare Pharma Description and Business Overview
6.1.3 AdvaCare Pharma Meglumine Diatrizoate Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AdvaCare Pharma Meglumine Diatrizoate Injection Product Portfolio
6.1.5 AdvaCare Pharma Recent Developments/Updates
6.2 Shanghai Xudong Haipu Pharmaceutical
6.2.1 Shanghai Xudong Haipu Pharmaceutical Company Information
6.2.2 Shanghai Xudong Haipu Pharmaceutical Description and Business Overview
6.2.3 Shanghai Xudong Haipu Pharmaceutical Meglumine Diatrizoate Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Shanghai Xudong Haipu Pharmaceutical Meglumine Diatrizoate Injection Product Portfolio
6.2.5 Shanghai Xudong Haipu Pharmaceutical Recent Developments/Updates
6.3 Hunan Hansen Pharmaceutical
6.3.1 Hunan Hansen Pharmaceutical Company Information
6.3.2 Hunan Hansen Pharmaceutical Description and Business Overview
6.3.3 Hunan Hansen Pharmaceutical Meglumine Diatrizoate Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hunan Hansen Pharmaceutical Meglumine Diatrizoate Injection Product Portfolio
6.3.5 Hunan Hansen Pharmaceutical Recent Developments/Updates
6.4 Shanghai Bracco Sine Pharmaceutical
6.4.1 Shanghai Bracco Sine Pharmaceutical Company Information
6.4.2 Shanghai Bracco Sine Pharmaceutical Description and Business Overview
6.4.3 Shanghai Bracco Sine Pharmaceutical Meglumine Diatrizoate Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Shanghai Bracco Sine Pharmaceutical Meglumine Diatrizoate Injection Product Portfolio
6.4.5 Shanghai Bracco Sine Pharmaceutical Recent Developments/Updates
6.5 Lunan Pharmaceutical
6.5.1 Lunan Pharmaceutical Company Information
6.5.2 Lunan Pharmaceutical Description and Business Overview
6.5.3 Lunan Pharmaceutical Meglumine Diatrizoate Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Lunan Pharmaceutical Meglumine Diatrizoate Injection Product Portfolio
6.5.5 Lunan Pharmaceutical Recent Developments/Updates
6.6 Xi'an Hanfeng Pharmaceutical
6.6.1 Xi'an Hanfeng Pharmaceutical Company Information
6.6.2 Xi'an Hanfeng Pharmaceutical Description and Business Overview
6.6.3 Xi'an Hanfeng Pharmaceutical Meglumine Diatrizoate Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Xi'an Hanfeng Pharmaceutical Meglumine Diatrizoate Injection Product Portfolio
6.6.5 Xi'an Hanfeng Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Meglumine Diatrizoate Injection Industry Chain Analysis
7.2 Meglumine Diatrizoate Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Meglumine Diatrizoate Injection Production Mode & Process Analysis
7.4 Meglumine Diatrizoate Injection Sales and Marketing
7.4.1 Meglumine Diatrizoate Injection Sales Channels
7.4.2 Meglumine Diatrizoate Injection Distributors
7.5 Meglumine Diatrizoate Injection Customer Analysis
8 Meglumine Diatrizoate Injection Market Dynamics
8.1 Meglumine Diatrizoate Injection Industry Trends
8.2 Meglumine Diatrizoate Injection Market Drivers
8.3 Meglumine Diatrizoate Injection Market Challenges
8.4 Meglumine Diatrizoate Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Advacare Pharma
Shanghai Xudong Haipu Pharmaceutical
Hunan Hansen Pharmaceutical
Lunan Pharmaceutical
Xi'an Hanfeng Pharmaceutical
Shanghai Bracco Sine Pharmaceutical
List of Tables
 Table 1. Global Meglumine Diatrizoate Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Meglumine Diatrizoate Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Meglumine Diatrizoate Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Meglumine Diatrizoate Injection Sales (K Bottles) of Key Manufacturers (2020-2025)
 Table 5. Global Meglumine Diatrizoate Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Meglumine Diatrizoate Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Meglumine Diatrizoate Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Meglumine Diatrizoate Injection Average Price (US$/Bottle) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Meglumine Diatrizoate Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Meglumine Diatrizoate Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Meglumine Diatrizoate Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Meglumine Diatrizoate Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Meglumine Diatrizoate Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meglumine Diatrizoate Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Meglumine Diatrizoate Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Meglumine Diatrizoate Injection Sales by Region (2020-2025) & (K Bottles)
 Table 18. Global Meglumine Diatrizoate Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Meglumine Diatrizoate Injection Sales by Region (2026-2031) & (K Bottles)
 Table 20. Global Meglumine Diatrizoate Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Meglumine Diatrizoate Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Meglumine Diatrizoate Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Meglumine Diatrizoate Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Meglumine Diatrizoate Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Meglumine Diatrizoate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Meglumine Diatrizoate Injection Sales by Country (2020-2025) & (K Bottles)
 Table 27. North America Meglumine Diatrizoate Injection Sales by Country (2026-2031) & (K Bottles)
 Table 28. North America Meglumine Diatrizoate Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Meglumine Diatrizoate Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Meglumine Diatrizoate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Meglumine Diatrizoate Injection Sales by Country (2020-2025) & (K Bottles)
 Table 32. Europe Meglumine Diatrizoate Injection Sales by Country (2026-2031) & (K Bottles)
 Table 33. Europe Meglumine Diatrizoate Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Meglumine Diatrizoate Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Meglumine Diatrizoate Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Meglumine Diatrizoate Injection Sales by Region (2020-2025) & (K Bottles)
 Table 37. Asia Pacific Meglumine Diatrizoate Injection Sales by Region (2026-2031) & (K Bottles)
 Table 38. Asia Pacific Meglumine Diatrizoate Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Meglumine Diatrizoate Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Meglumine Diatrizoate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Meglumine Diatrizoate Injection Sales by Country (2020-2025) & (K Bottles)
 Table 42. Latin America Meglumine Diatrizoate Injection Sales by Country (2026-2031) & (K Bottles)
 Table 43. Latin America Meglumine Diatrizoate Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Meglumine Diatrizoate Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Meglumine Diatrizoate Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Meglumine Diatrizoate Injection Sales by Country (2020-2025) & (K Bottles)
 Table 47. Middle East and Africa Meglumine Diatrizoate Injection Sales by Country (2026-2031) & (K Bottles)
 Table 48. Middle East and Africa Meglumine Diatrizoate Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Meglumine Diatrizoate Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Meglumine Diatrizoate Injection Sales (K Bottles) by Type (2020-2025)
 Table 51. Global Meglumine Diatrizoate Injection Sales (K Bottles) by Type (2026-2031)
 Table 52. Global Meglumine Diatrizoate Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Meglumine Diatrizoate Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Meglumine Diatrizoate Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Meglumine Diatrizoate Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Meglumine Diatrizoate Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Meglumine Diatrizoate Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Meglumine Diatrizoate Injection Price (US$/Bottle) by Type (2020-2025)
 Table 59. Global Meglumine Diatrizoate Injection Price (US$/Bottle) by Type (2026-2031)
 Table 60. Global Meglumine Diatrizoate Injection Sales (K Bottles) by Application (2020-2025)
 Table 61. Global Meglumine Diatrizoate Injection Sales (K Bottles) by Application (2026-2031)
 Table 62. Global Meglumine Diatrizoate Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Meglumine Diatrizoate Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Meglumine Diatrizoate Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Meglumine Diatrizoate Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Meglumine Diatrizoate Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Meglumine Diatrizoate Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Meglumine Diatrizoate Injection Price (US$/Bottle) by Application (2020-2025)
 Table 69. Global Meglumine Diatrizoate Injection Price (US$/Bottle) by Application (2026-2031)
 Table 70. AdvaCare Pharma Company Information
 Table 71. AdvaCare Pharma Description and Business Overview
 Table 72. AdvaCare Pharma Meglumine Diatrizoate Injection Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 73. AdvaCare Pharma Meglumine Diatrizoate Injection Product
 Table 74. AdvaCare Pharma Recent Developments/Updates
 Table 75. Shanghai Xudong Haipu Pharmaceutical Company Information
 Table 76. Shanghai Xudong Haipu Pharmaceutical Description and Business Overview
 Table 77. Shanghai Xudong Haipu Pharmaceutical Meglumine Diatrizoate Injection Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 78. Shanghai Xudong Haipu Pharmaceutical Meglumine Diatrizoate Injection Product
 Table 79. Shanghai Xudong Haipu Pharmaceutical Recent Developments/Updates
 Table 80. Hunan Hansen Pharmaceutical Company Information
 Table 81. Hunan Hansen Pharmaceutical Description and Business Overview
 Table 82. Hunan Hansen Pharmaceutical Meglumine Diatrizoate Injection Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 83. Hunan Hansen Pharmaceutical Meglumine Diatrizoate Injection Product
 Table 84. Hunan Hansen Pharmaceutical Recent Developments/Updates
 Table 85. Shanghai Bracco Sine Pharmaceutical Company Information
 Table 86. Shanghai Bracco Sine Pharmaceutical Description and Business Overview
 Table 87. Shanghai Bracco Sine Pharmaceutical Meglumine Diatrizoate Injection Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 88. Shanghai Bracco Sine Pharmaceutical Meglumine Diatrizoate Injection Product
 Table 89. Shanghai Bracco Sine Pharmaceutical Recent Developments/Updates
 Table 90. Lunan Pharmaceutical Company Information
 Table 91. Lunan Pharmaceutical Description and Business Overview
 Table 92. Lunan Pharmaceutical Meglumine Diatrizoate Injection Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 93. Lunan Pharmaceutical Meglumine Diatrizoate Injection Product
 Table 94. Lunan Pharmaceutical Recent Developments/Updates
 Table 95. Xi'an Hanfeng Pharmaceutical Company Information
 Table 96. Xi'an Hanfeng Pharmaceutical Description and Business Overview
 Table 97. Xi'an Hanfeng Pharmaceutical Meglumine Diatrizoate Injection Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 98. Xi'an Hanfeng Pharmaceutical Meglumine Diatrizoate Injection Product
 Table 99. Xi'an Hanfeng Pharmaceutical Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Meglumine Diatrizoate Injection Distributors List
 Table 103. Meglumine Diatrizoate Injection Customers List
 Table 104. Meglumine Diatrizoate Injection Market Trends
 Table 105. Meglumine Diatrizoate Injection Market Drivers
 Table 106. Meglumine Diatrizoate Injection Market Challenges
 Table 107. Meglumine Diatrizoate Injection Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Meglumine Diatrizoate Injection
 Figure 2. Global Meglumine Diatrizoate Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Meglumine Diatrizoate Injection Market Share by Type: 2024 & 2031
 Figure 4. 1ml/0.3g Product Picture
 Figure 5. 20ml/15.2g Product Picture
 Figure 6. 20ml/12g Product Picture
 Figure 7. 100ml/60g Product Picture
 Figure 8. Global Meglumine Diatrizoate Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Meglumine Diatrizoate Injection Market Share by Application: 2024 & 2031
 Figure 10. Hospital
 Figure 11. Clinic
 Figure 12. Pharmacy
 Figure 13. Global Meglumine Diatrizoate Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Meglumine Diatrizoate Injection Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Meglumine Diatrizoate Injection Sales (2020-2031) & (K Bottles)
 Figure 16. Global Meglumine Diatrizoate Injection Average Price (US$/Bottle) & (2020-2031)
 Figure 17. Meglumine Diatrizoate Injection Report Years Considered
 Figure 18. Meglumine Diatrizoate Injection Sales Share by Manufacturers in 2024
 Figure 19. Global Meglumine Diatrizoate Injection Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Meglumine Diatrizoate Injection Players: Market Share by Revenue in Meglumine Diatrizoate Injection in 2024
 Figure 21. Meglumine Diatrizoate Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Meglumine Diatrizoate Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Meglumine Diatrizoate Injection Sales Market Share by Country (2020-2031)
 Figure 24. North America Meglumine Diatrizoate Injection Revenue Market Share by Country (2020-2031)
 Figure 25. United States Meglumine Diatrizoate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Meglumine Diatrizoate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Meglumine Diatrizoate Injection Sales Market Share by Country (2020-2031)
 Figure 28. Europe Meglumine Diatrizoate Injection Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Meglumine Diatrizoate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Meglumine Diatrizoate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Meglumine Diatrizoate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Meglumine Diatrizoate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Meglumine Diatrizoate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Meglumine Diatrizoate Injection Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Meglumine Diatrizoate Injection Revenue Market Share by Region (2020-2031)
 Figure 36. China Meglumine Diatrizoate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Meglumine Diatrizoate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Meglumine Diatrizoate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Meglumine Diatrizoate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Meglumine Diatrizoate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Meglumine Diatrizoate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Meglumine Diatrizoate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Meglumine Diatrizoate Injection Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Meglumine Diatrizoate Injection Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Meglumine Diatrizoate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Meglumine Diatrizoate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Meglumine Diatrizoate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Meglumine Diatrizoate Injection Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Meglumine Diatrizoate Injection Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Meglumine Diatrizoate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Meglumine Diatrizoate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Meglumine Diatrizoate Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Meglumine Diatrizoate Injection by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Meglumine Diatrizoate Injection by Type (2020-2031)
 Figure 55. Global Meglumine Diatrizoate Injection Price (US$/Bottle) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Meglumine Diatrizoate Injection by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Meglumine Diatrizoate Injection by Application (2020-2031)
 Figure 58. Global Meglumine Diatrizoate Injection Price (US$/Bottle) by Application (2020-2031)
 Figure 59. Meglumine Diatrizoate Injection Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Gadoterate Meglumine Market Research Report 2024
Global Iohexol Injection Market Research Report 2024
Global Medical Contrast Media Injectors Market Insights Forecast to 2030
Global Meglumine Adenosine Cyclophosphate Injection Market Research Report 2024
Global Iopamidol Injection Market Research Report 2024
Global Sodium Diatrizoate Hydrate Market Research Report 2024
Global Iodixanol Injection Market Research Report 2024
Global Gadopentetic Acid Dimeglumine Salt Injection Market Research Report 2024
Global Dual Head Contrast Media Injector Market Research Report 2024
Global Flunixin Meglumine Injection Market Research Report 2024
Global Industrial Solid Iohexol Market Research Report 2024
Global Gadodiamide Market Research Report 2024
Global Sodium Pertechnetate 99mTc Injection Market Research Report 2024
Global DSA Contrast Media Injector Market Research Report 2024
Global Gadopentetate Dimeglumine Market Research Report 2024
Global Polygeline Injection Market Research Report 2024
Angiography Syringe Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gadolinium Contrast Agent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dexamethasone Sodium Phosphate Injection Market Research Report 2024
Global Gadoteric Acid Meglumine Salt Injection Market Research Report 2025

RELATED REPORTS

Global Blood Bank (Blood Banking) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-198
Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Cryotherapy Units Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

120 Pages
Type: Report
Code: QYRE-Auto-36U12799
Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Bone Biopsy Systems Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-1U19508
Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Global Spinal Surgery Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27W19166
Mon Jun 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions